|
HCCS expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.83820000834822E-09 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.73030000327756E-08 |
| Normal-vs-Stage2 |
5.445200E-01 |
| Normal-vs-Stage3 |
3.3907999741345E-09 |
| Normal-vs-Stage4 |
4.04376532259221E-12 |
| Stage1-vs-Stage2 |
2.025900E-02 |
| Stage1-vs-Stage3 |
1.458980E-01 |
| Stage1-vs-Stage4 |
1.019670E-03 |
| Stage2-vs-Stage3 |
4.221100E-03 |
| Stage2-vs-Stage4 |
2.199700E-04 |
| Stage3-vs-Stage4 |
1.072780E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.49390533066685E-11 |
| Normal-vs-AfricanAmerican |
1.87530999999908E-05 |
| Normal-vs-Asian |
5.59259999999284E-05 |
| Caucasian-vs-AfricanAmerican |
9.823400E-01 |
| Caucasian-vs-Asian |
5.896200E-01 |
| AfricanAmerican-vs-Asian |
7.190800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.82039999740979E-08 |
| Normal-vs-Female |
1.94129999853132E-08 |
| Male-vs-Female |
2.544200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.05080000046121E-08 |
| Normal-vs-Age(41-60Yrs) |
4.18409973335088E-10 |
| Normal-vs-Age(61-80Yrs) |
2.522200E-03 |
| Normal-vs-Age(81-100Yrs) |
3.443100E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.125200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.352400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.430400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.537700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.531200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.692000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.774800E-01 |
| Classical-VS-Follicular |
6.567600E-04 |
| Classical-VS-Other |
2.016200E-01 |
| Classical-VS-Normal |
1.65820024378149E-10 |
| Tall-VS-Follicular |
3.414100E-04 |
| Tall-VS-Other |
4.478800E-01 |
| Tall-VS-Normal |
3.34790000167118E-08 |
| Follicular-VS-Other |
3.342100E-03 |
| Follicular-VS-Normal |
3.140200E-01 |
| Other-VS-Normal |
6.24889999999434E-05 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.3777000002223E-07 |
| Normal-vs-N1 |
7.57716112076423E-12 |
| N0-vs-N1 |
1.043900E-03 |
|
|
